Effect of central nervous system metastases on treatment discontinuation and survival in older women receiving trastuzumab for metastatic breast cancer.

Journal article

Background. Trastuzumab improves survival in HER2-positive women with metastatic breast cancer (MBC). The consequences of longer survival include a higher likelihood of additional metastases, including those in the central nervous system (CNS). The effect of CNS metastases on both trastuzumab discontinuation and survival in older patients has not been described. Patients and Methods. We used the Surveillance Epidemiology and End Results (SEER) Medicare data to identify a cohort of 562 women a...

Expand abstract

Authors: Danese, MD; Lindquist, K; Doan, J; Lalla, D; Brammer, M

• Journal: Journal of cancer epidemiology
• Volume: 2012
• Pages: 819210
• Publication date: 2012-01-01
• DOI: 10.1155/2012/819210
• EISSN: 1687-8566
• ISSN: 1687-8558
• Language: English